Table 1: Patient characteristics, retention in care and loss to follow-up from urban ART program in Ghana.

Patient

Characteristics

Patient

Category (N = 370)

Retention in care

Loss to follow-up

Gender

Female 258 (69.3%)

188 (72.9%)

70 (27.1%)

Male 112 (30.7%)

72 (64.3%)

40 (35.7%)

Age Group

(Years)

21-40 200 (54.1%)

135 (67.5%)

65 (32.5%)

41-60 160 (43.2%)

118 (73.8%)

42 (26.2%)

61-80 10 (2.7%)

7 (70.0%)

3 (30.0%)

Occupation

Employed 333 (90%)

240 (72.1%)

93 (27.9%)

Unemployed 37 (10%)

20 (54.1%)

17 (45.9%)

Education

Primary 199 (53.8%)

150 (75.4%)

49 (24.6%)

Secondary 28 (7.6%)

16 (57.1%)

12 (42.9%)

Tertiary 16 (4.3%)

8 (50%)

8 (50%)

Uneducated 127 (34.3%)

86 (67.7%)

41 (32.3%)

Marital status

Divorced 72 (19.5%)

60 (83.3%)

12 (16.7%)

Married 146 (39.5%)

91 (62.3%)

55 (37.7%)

Single 89 (24.1%)

59 (66.3%)

30 (33.7%)

Widowed 63 (17.0%)

50 (79.4%)

13 (20.6%)

ART initiation Regimen

AZT/3TC/EFV 88 (23.8%)

54 (61.4%)

34 (38.6%)

AZT/3TC/NVP 109 (29.5%)

79 (72.5%)

30 (27.5%)

TDF/3TC/EFV 114 (30.8%)

86 (75.4%)

29 (26.4%)

TDF/3TC/NVP 59 (15.9%)

42 (71.2%)

17 (28.8%)

Note: TDF is tenofovir disoproxyl fumarate, AZT is azidothymidine (zidovudine), 3 TC is lamivudine, NVP is nevirapine and EFV is efavirenz